Clearline Capital’s Sotera Health SHC Stock Holding History

Clearline Capital’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-143,826	Closed	-$1.71M	–	166
2024 Q2	$1.71M	Buy	+143,826	New	+$1.64M	0.05%	97

Other funds holding SHC

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

DCP

Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

MIG Capital Newport Beach, California $589M AUM 25.96% 1-Year Est. Return

Clearline Capital's SHC Position: Q3 2024 in Review

Clearline Capital sold out of Sotera Health (SHC) in Q3 2024, closing a stake of 143,826 shares — an estimated $1.71M sold.

Clearline Capital first reported a position in SHC in Q2 2024 and held it in 1 quarter. The position peaked at $1.71M in Q2 2024. 209 funds tracked by Wall St. Rank hold SHC as of Q3 2024.

Clearline Capital reported no remaining Sotera Health position as of Q3 2024 after selling out during the quarter.
Clearline Capital sold 143,826 Sotera Health shares in Q3 2024, an estimated $1.71M.
Clearline Capital first reported a position in Sotera Health in Q2 2024 and held it in 1 quarter.
Clearline Capital's Sotera Health position peaked at $1.71M in Q2 2024.
209 funds tracked by Wall St. Rank held Sotera Health as of Q3 2024.

Based on Clearline Capital's 13F filing for Q3 2024, filed 14 Nov 2024.